XML 25 R15.htm IDEA: XBRL DOCUMENT v3.24.2
NOTE 9 – STOCKHOLDERS’ EQUITY
9 Months Ended
May 31, 2024
Equity [Abstract]  
NOTE 9 – STOCKHOLDERS’ EQUITY

NOTE 9 – STOCKHOLDERS’ EQUITY

 

Common shares

  

The Company had the following activities for the nine months ended May 31, 2024:

 

Issuance of restricted common shares

 

On October 5, 2023, the Board of Directors resolved to issue 225,000,000 shares of the Company’s restricted common stock, par value $0.001 per share, to Chiyuan Deng, the Chief Executive Officer, to pay off his accrued executive salaries of $45,000.

 

Conversion of Series C preferred shares to common shares

 

During the nine months ended May 31, 2024, the Company issued a total of 1,056,681,936 common shares as the result of the conversion of total 174,421 Series C preferred shares.

 

Reverse Stock split

 

As previously disclosed in the Company’s Form 10-Q for the quarter ended May 31, 2023, on June 12, 2023, the Board of Directors approved a reverse split for the Company’s issued and outstanding common stock, at a ratio of 1 share for every 10,000 shares, contingent upon receiving a market effectiveness date from FINRA.

 

On April 22, 2024, the Board of Directors approved a reverse split of the Corporation’s issued and outstanding common stock, which has a par value $0.001 per share. The reverse split ratio has been determined at 1 for 2,000 shares. The effectiveness of this reverse split is contingent upon receiving a market effective date from the Financial Industry Regulatory Authorization (FINRA).

 

Cancellation of Common shares

 

On February 5, 2024, our majority shareholder, officer and director, Chiyuan Deng, cancelled 235,000,000 shares of his common stock in the Company.

 

The Company had the following activities for the nine months ended May 31, 2023: 

 

Increasing authorized number of common shares

 

On October 11, 2022, the Company filed amendment to Articles of Incorporation to increase the authorized number of common shares from 1,000,000,000 shares to 10,000,000,000 shares. This increasing of authorized number of common shares has been retroactively reflected in the consolidated financial statements and notes thereto.

 

Conversion of Series C preferred shares to common shares

 

During the three months ended November 30, 2022, the Company issued a total of 75,037,786 common shares as the result of the conversion of total 96,075 Series C preferred shares.

 

During the three months ended February 28, 2023, the Company issued a total of 221,354,447 common shares as the result of the conversion of total 81,075 Series C preferred shares.

 

During the three months ended May 31, 2023, the Company issued a total of 293,378,569 common shares as the result of the conversion of total 65,264 Series C preferred shares.

 

 

AB INTERNATIONAL GROUP CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 9 – STOCKHOLDERS’ EQUITY (continued)

 

Common shares (continued)

 

Subscription of Common shares

 


On August 2, 2022, the Company entered into a common stock purchase agreement with Alumni Capital LP, a Delaware limited partnership. Pursuant to the agreement, Alumni Capital LP shall purchase $1.0 million of common stocks as per the Company’s discretions after a Registration Statement is declared effective by the Securities and Exchange Commission. The purchase price is number of common stocks in a Purchase Notice issued by the Company multiplied by 75% of the lowest traded price of the Common Stock five Business Days prior to the Closing, which is no later than five business days after the Purchase Notice Date. 

 


The Company plans to use the proceeds from the sale of the common stocks for general corporate and working capital purposes and acquisitions or assets, businesses or operations or for other purposes that the Board of Directors, in good faith deem to be in the best interest of the Company. The registration of these securities was effective on September 13, 2022.

 

Pursuant to this agreement, during the nine months ended May 31, 2023, Alumni Capital LP subscribed for a total of 200,000,000 common shares for total proceeds of $146,475. The agreement expired on December 31, 2022.

 

As of May 31, 2024 and August 31, 2023, the Company had 2,331,965,321 and 1,285,283,385 common shares issued and outstanding, respectively.

 

A summary of the status of the Company’s warrants as of May 31, 2024 and August 31, 2023 is presented below.

 

   Number of warrants
   Original shares issued  Anti-dilution Adjusted
Warrants as of August 31, 2022   50,000,000       
Warrants granted during the year            
Warrants as of August 31, 2023   50,000,000       
Warrants granted during the nine months            
Exercisable as of May 31, 2024   50,000,000       

 

Preferred shares

 

The Company had the following activities for the nine months ended May 31, 2024:

 

During the nine months ended May 31, 2024, the Company converted a total 174,421 Series C preferred shares into common shares.

 

On November 30, 2023, the Board of Directors of the Company resolved to withdraw the Amended Certificate of Designation for the Company’s Series C and Series D Preferred shares.

 

 

AB INTERNATIONAL GROUP CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 9 – STOCKHOLDERS’ EQUITY (continued)

 

Preferred shares (continued)

 

On December 1, 2023, the Board of Directors of the Company resolved to withdraw the Certificate of Designation for the Company’s Series B Preferred Stock. The Company’s Series B Preferred Stock was cancelled during the three months ended February 29, 2024.

 

The Company had the following activities for the nine months ended May 31, 2023: 

 

On September 6, 2022, the Company entered into a securities purchase agreement with an accredited investor, whereby investor purchased from the Company 90,275 shares of Series C Convertible Preferred Stock of the Company for a gross proceed of $78,500. After deduction of transaction-related expenses, net proceed to the Company was $69,000. The Company intends to use the proceeds from the Preferred Stock for general working capital purposes.

 

The Company recorded dividend expenses of $14,545 on Series C and D Preferred shares for the nine months ended May 31, 2023.